Citation: | HU Gen, LI Wei, SHAO Guoyi, ZHANG Xian. Predictive Effect of Preoperative Platelet-lymphocyte Ratio on Prognosis of Patients with Gastric Stromal Tumor[J]. Cancer Research on Prevention and Treatment, 2018, 45(7): 479-482. DOI: 10.3971/j.issn.1000-8578.2018.17.1428 |
To assess whether preoperative platelet-lymphocyte ratio(PLR) is an effective prognostic marker for gastric stromal tumor(GST) patients.
We retrospectively analyzed the clinical data of 92 patients with gastric stromal tumor. The PLR data of peripheral blood samples on the third day before surgery and immunohistochemistry results of all patients were collected. According to preoperative PLR, the patients were divided into low PLR group(PLR < 130, n=38) and high PLR group(PLR≥130, n=54). The survival of GST patients was compared between two groups and the relationship of clinical pathological characteristics with overall survival and postoperative recurrence-free survival were analyzed.
The preoperative PLR was related to mitotic?gures(χ2=5.95, P=0.015). The recurrence-free survival of the patients with high PLR was lower than that with low PLR before operation(χ2=6.17, P=0.018). The recurrence-free survival was associated with preoperative PLR, adjuvant treatment with imatinib, NIH risk category, mitotic?gures and tumor size in univariate analysis(P < 0.05). The preoperative PLR was independent prognostic indicator for recurrence-free survival of GST patients in Cox multivariate analysis (P < 0.05).
Preoperative PLR may be an independent prognostic factor for patients with gastric stromal tumor. High PLR before operation may indicate poor prognosis.
[1] |
Kitamura Y. Gastrointestinal stromal tumors: past, present, and future[J]. J Gastroenterol, 2008, 43(7): 499-508. doi: 10.1007/s00535-008-2200-y
|
[2] |
Feng F, Tian Y, Liu S, et al. Combination of PLR, MLR, MWR, and Tumor Size Could Significantly Increase the Prognostic Value for Gastrointestinal Stromal Tumors[J]. Medicine (Baltimore), 2016, 95(14): e3248. doi: 10.1097/MD.0000000000003248
|
[3] |
章志丹, 张君严, 鲁翀.结直肠癌患者血小板与淋巴细胞比值对预后影响Meta分析[J].中华肿瘤防治杂志, 2016, 23(20): 1376-81. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_syazzz201407006
Zhang ZD, Zhang JY, Lu C. Prognosic value of platelet to lymphocyte ratio in patients with colorectal cancer: A meta analysis[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2016, 23(20): 1376-81. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_syazzz201407006
|
[4] |
刘海亮, 杜晓辉, 孙培鸣, 等.术前血小板与淋巴细胞比值对结直肠癌预后的影响[J].南方医科大学学报, 2013, 33(1): 70-3. http://www.cqvip.com/QK/87239A/201428/662475391.html
Liu HL, Du XH, Sun PM, et al. Preoperative platelet-lymphocyte ratio is an independent prognostic factor for resectable colorectal cancer[J]. Nanfang Yi Ke Da Xue Xue Bao, 2013, 33(1): 70-3. http://www.cqvip.com/QK/87239A/201428/662475391.html
|
[5] |
张明辉, 徐光如, 徐金华, 等.胃癌患者术前血小板/淋巴细胞比值的预后意义[J].临床肿瘤学杂志, 2016, 21(10): 913-8. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zglcyx201603025
Zhang MH, Xu GR, Xu JH, et al. Prognostec significance of reoperative platelet-lymphocyte ratio in patients with gastric cancer[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2016, 21(10): 913-8. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zglcyx201603025
|
[6] |
胡逸林, 李勇, 沈雁兵.血小板/淋巴细胞比值与胃癌分期及转移情况关系的临床研究[J].腹部外科, 2015, 28(6): 451-4. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=fbwk201506020
Hu YL, Li Y, Shen YB. A clinical study of the relationship between platelet/lymphocyte ratio and staging, metastatic of gastric cancer[J]. Fu Bu Wai Ke, 2015, 28(6): 451-4. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=fbwk201506020
|
[7] |
张维维, 马丹宇, 李小庭, 等.术前血小板/淋巴细胞比值与卵巢癌患者预后的关系[J].实用医学杂志, 2014, 30(23): 3781-4. doi: 10.3969/j.issn.1006-5725.2014.23.024
Zhang ww, Ma DY, Li XT, et al. Relationship between preoperative platelet/lymphocyte ratio and prognosis of ovarian cancer[J]. Shi Yong Yi Xue Za Zhi, 2014, 30(23): 3781-4. doi: 10.3969/j.issn.1006-5725.2014.23.024
|
[8] |
郭雪芬, 王若雨, 李贺明, 等.外周血血小板/淋巴细胞比值与胆道系统肿瘤预后的相关性[J].肿瘤学杂志, 2017, 23(4): 300-4. doi: 10.11735/j.issn.1671-170X.2017.04.B010
Guo XF, Wang RY, Li HM, et al. Relationship of peripheral blood platelet to lymphocyte ratio with clinicopathological features features and prognosis of biliary tract cancer[J]. Zhong Liu Xue Za Zhi, 2017, 23(4): 300-4. doi: 10.11735/j.issn.1671-170X.2017.04.B010
|
[9] |
洪进, 毛艳, 陈小松, 等.血小板和淋巴细胞计数对乳腺癌患者预后的预测价值[J].上海交通大学学报(医学版), 2016, 36(3): 369-74. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_shdeykdxxb201603011
Hong J, Mao Y, Chen XS, et al. Significance of platelet and lymphocyte counts for predicting the prognosis of patients with breast cancer[J]. Shanghai Jiao Tong Da Xue Xue Bao(Yi Xue Ban), 2016, 36(3): 369-74. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_shdeykdxxb201603011
|
[10] |
胡赟宏, 王铮元, 崔嵘嵘, 等.中性粒细胞/淋巴细胞比值与血小板/淋巴细胞比值对乳腺癌复发转移的预测价值及乳腺癌预后影响因素研究[J].中国全科医学, 2016, 19(30): 3657-61. doi: 10.3969/j.issn.1007-9572.2016.30.003
Hu YH, Wang ZY, Cui RR, et al. Predictive value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on recurrence and metastasis of breast cancer and influencing factors on breast cancer prognosis[J]. Zhongguo Quan Ke Yi Xue, 2016, 19(30): 3657-61. doi: 10.3969/j.issn.1007-9572.2016.30.003
|
[11] |
Demetri GD, von Mehren M, Antonescu CR, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors[J]. J Natl Compr Canc Netw, 2010, 8 Suppl 2: S1-41; quiz S42-44.
|
[12] |
Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation[J]. Nature, 2008, 454(7203): 436-44. doi: 10.1038/nature07205
|
[13] |
Jiang C, Hu WM, Liao FX, et al. Elevated preoperative neutrophil-to-lymphocyte ratio is associated with poor prognosis in gastrointestinal stromal tumor patients[J]. Onco Targets Ther, 2016, 9: 877-83. http://cn.bing.com/academic/profile?id=23a4314a4ac5e6a042dca1f098d0ee53&encoded=0&v=paper_preview&mkt=zh-cn
|
[14] |
Perez DR, Baser RE, Cavnar MJ, et al. Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor[J]. Ann Surg Oncol, 2013, 20(2): 593-9. doi: 10.1245/s10434-012-2682-y
|
[15] |
Goh BK, Chok AY, Allen JC, et al. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors[J]. Surgery, 2016, 159(4): 1146-56. doi: 10.1016/j.surg.2015.10.021
|
[16] |
Wu T, Li Y, Lu J, et al. Increased MMP-21 expression is associated with poor overall survival of patients with gastric cancer[J]. Med Oncol, 2013, 30(1): 323. doi: 10.1007/s12032-012-0323-8
|
[17] |
Stotz M, Liegl-Atzwanger B, Posch F, et al. Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection[J]. PLoS One, 2016, 11(7): e0159448. doi: 10.1371/journal.pone.0159448
|
[18] |
Racz JM, Cleghorn MC, Jimenez MC, et al. Predictive Ability of Blood Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Gastrointestinal Stromal Tumors[J]. Ann Surg Oncol, 2015, 22(7): 2343-50. doi: 10.1245/s10434-014-4265-6
|